2021
DOI: 10.1016/j.orthop.2021.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Microvascular free tissue transfer in the setting of COVID-19 associated coagulopathy: A case report

Abstract: In the era of this pandemic, the use of free flaps for elective reconstruction should proceed with caution in the COVID-19 positive patient given the associated coagulopathy. In those who require free tissue transfer in an urgent or non-elective manner, it is advisable to consider systemic anticoagulation with an associated hematologic consultation given the theoretic higher risk of flap vascular complication. We present a case report of a young healthy and otherwise asymptomatic COVID-19 positive p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…37,38 It is yet to be thoroughly studied whether previous or active COVID-19 infection affects free-flap survival though several anecdotal case reports do exist. [39][40][41][42] Although the ACS-NSQIP database does not account for COVID-19 status, it is possible that patients who become infected in the early postoperative period may be at increased risk of microvascular thrombosis and flap failure and other trends may be identified in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…37,38 It is yet to be thoroughly studied whether previous or active COVID-19 infection affects free-flap survival though several anecdotal case reports do exist. [39][40][41][42] Although the ACS-NSQIP database does not account for COVID-19 status, it is possible that patients who become infected in the early postoperative period may be at increased risk of microvascular thrombosis and flap failure and other trends may be identified in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…As shown in this case and other reports, free tissue transfer is possible for select patients, despite the hypercoagulability associated with COVID-19. 13,14 Our intention was to attempt conservative wound coverage strategies in the early stages of COVID-19 infection. One report of COVID-19 free tissue transfer recommends delaying reconstruction, and another report of lower extremity free tissue transfer in a patient with COVID-19 and a pilon fracture recommends an extended period of anticoagulation postoperatively, including 3 months of antiplatelet therapy and 6 months of therapeutic anticoagulation.…”
Section: Discussionmentioning
confidence: 99%
“…One report of COVID-19 free tissue transfer recommends delaying reconstruction, and another report of lower extremity free tissue transfer in a patient with COVID-19 and a pilon fracture recommends an extended period of anticoagulation postoperatively, including 3 months of antiplatelet therapy and 6 months of therapeutic anticoagulation. 13,14 Given the asymptomatic course of this patient's COVID-19 infection and the fact that she was more than 6 weeks past her initial positive result, a more conservative regimen consisting of 1 month of aspirin 81 mg and enoxaparin 40 mg daily chemoprophylaxis during bedrest was administered. Our patient's postoperative course was not complicated by sequelae of her COVID-19 infection, and the conservative regimen was successful in preventing any thromboembolic event.…”
Section: Discussionmentioning
confidence: 99%
“…The diameter mismatch between the vessels poses a problem in bringing them together, and the risk of thrombosis is high. Turbulence caused by sudden diameter changes triggers platelet aggregation [ 2 ]. Leakage may occur at anastomotic sites following femoral artery repair.…”
Section: Introductionmentioning
confidence: 99%